Private equity-backed healthcare technology company IMS Health has raised $1.3bn from its recent IPO.
The company sold 65,000,000 shares of at $20 per share, including 52,000,000 shares to be sold by IMS Health and 13,000,000 shares to be sold by shareholders.
The company, whose shareholders include TPG Capital Management, CPP Investment Board and Leonard Green & Partners, is valued at close to $7bn.
In addition, the selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 9,750,000 shares.
IMS Health said it expects to use substantially all of the net proceeds from the shares offered by it to repay existing long-term debt.
IMS Health’s customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Copyright © 2014 AltAssets